vimarsana.com

Page 22 - மோர்கன் ஸ்டான்லி முதலீடு மேலாண்மை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Eaton Vance Floating-Rate Income Trust Announces Results of Special Meeting of Shareholders, Increased Initial Tender Offer and Additional Conditional Tender Offers

Eaton Vance Senior Floating Rate Trust : Announce Increased Initial Tender Offer and Additional Conditional Tender Offers

and Additional Conditional Tender Offers BOSTON, MA, May 12, 2021 -As previously announced on March 16, 2021, the Board of Eaton Vance Senior Floating-Rate Trust (NYSE: EFR) (the Fund ) authorized a conditional cash tender offer for up to 25% of the Fund s outstanding common shares at a price per share equal to 99% of the Fund s net asset value per share ( NAV ) as of the close of regular trading on the New York Stock Exchange ( NYSE ) on the date the tender offer expires, conditioned on Fund shareholders approving a new investment advisory agreement (the New Agreement ) between the Fund and Eaton Vance Management (the Initial Tender Offer ). The Fund is announcing today an increase in the amount of the Initial Tender Offer from up to 25% of the Fund s outstanding shares to up to 50% of the Fund s outstanding common shares. All other terms of the Initial Tender Offer are as previously announced. If the New Agreement is approved, the Initial Tender Offer would com

Eaton Vance Senior Income Trust Announces Conditional Tender Offers and Special Meeting of Shareholders

Eaton Vance Senior Floating-Rate Trust Announces Increased Initial Tender Offer and Additional Conditional Tender Offers

Ginkgo Bioworks to Become a Public Company and Expand its Leading Platform for Cell Programming

Ginkgo Bioworks to Become a Public Company and Expand its Leading Platform for Cell Programming Ginkgo is building the leading horizontal platform for synthetic biology, making it possible to program cells as easily as we can program computers and enabling innovation across industries, including therapeutics, industrials, food and agriculture News provided by Share this article BOSTON and LOS ANGELES, May 11, 2021 /PRNewswire/ Business combination with Soaring Eagle Acquisition Corp. (Nasdaq:SRNG) values Ginkgo Bioworks, Inc. at a $15 billion pre-money equity valuation and is expected to provide up to $2.5 billion of primary proceeds. Institutional investors have committed $775 million in an oversubscribed PIPE, with anchor investments from Baillie Gifford, Putnam Investments, and funds and accounts managed by Counterpoint Global (Morgan Stanley Investment Management). New investors including accounts advised by ARK Investment Management LLC, ArrowMark Partners, Bain Capital

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.